The fourth PRECISEU Personalised Medicine School will take place from 16–20 November 2026, bringing together researchers, clinicians and industry professionals to explore advances in the clinical translation and manufacturing of ATMPs and RNA medicines.
The fourth PRECISEU Personalised Medicine School will take place from 16–20 November 2026, bringing together researchers, clinicians and industry professionals to explore advances in the clinical translation and manufacturing of ATMPs and RNA medicines.
Under the theme “The Future of ATMP Translation and Next-Generation Manufacturing”, the five-day programme will examine the scientific, technological and collaborative approaches needed to accelerate the development of personalised therapies and improve patient access across Europe.
The event will combine a hybrid opening workshop with four days of online masterclasses, featuring experts from NIBRT, CONCEPT, Rinn Advanced Therapies, and Rinn Pharma and Biopharma. The programme will explore key areas including early-stage biotherapy development, manufacturing innovation, RNA medicine translation and glycobiology.
The school will open on Monday, 16 November, with a hybrid workshop “Collaboration Models for ATMP Development“, led by Dr Friedemann Loos, Innovation Manager at bioRN Life Science Cluster.
The subsequent online sessions will cover several key areas of advanced therapy development and manufacturing.
Programme Highlights
Monday, 16 November | Hybrid
Collaboration Models for ATMP Development
Dr Friedemann Loos, bioRN Life Science Cluster
Tuesday, 17 November | Online
Measuring What Matters Early: Characterisation, Potency and Translation-Ready Advanced Therapy Research
Dr Clair Gallagher, Dr. Ioanna Tzani, Dr. Julia Serna and Dr. Oisin King, CONCEPT
Trends in Biopharmaceuticals and their Manufacture – “Solutions in a rapidly changing landscape”
Dr John Milne, NIBRT
Wednesday, 18 November | Online
Cell Immunotherapy Manufacturing Science and Technology (MSAT)
Prof Elena Matsa, NIBRT, University College Cork and Rinn Advanced Therapies
Thursday, 19 November | Online
Research Insights into Clinical Translation of RNA Medicines
Prof Damien Thompson, Prof Steven Ferguson and Prof Piotr Kowalski, Rinn Pharma and Biopharma
Friday, 20 November | Online
Applications of Glycobiology: From Glycan Analysis to Glycoengineering
Prof Radka Fahey and Prof Michael Butler, NIBRT
Connecting the Dots in ATMP Development
The PRECISEU Personalised Medicine School aims to strengthen the knowledge, expertise and cross-sector connections needed to support coordinated efforts across scientific development, manufacturing, regulation and healthcare systems.
The programme is open to researchers, clinicians, industry professionals, entrepreneurs, policymakers and other stakeholders involved in advanced therapies and personalised medicine.
Register
